Index by author

01 November 2005; volume 26, issue 5

A

  1. Achouh, L.

    1. Montani, D. et al "Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease." European Respiratory Journal 26.5 (2005): 969-972. Web. 18 Jan. 2020.

  2. Adcock, I. M.

    1. Chung, K. F., and I. M. Adcock. "Signalling and transcriptional regulation in inflammatory and immune cells: importance in lung biology and disease." European Respiratory Journal 26.5 (2005): 762-763. Web. 18 Jan. 2020.

  3. Alatas, F.

    1. Metintas, M. et al "Nonmalignant pleural lesions due to environmental exposure to asbestos: a field-based, cross-sectional study." European Respiratory Journal 26.5 (2005): 875-880. Web. 18 Jan. 2020.

  4. Alison, J. A.

    1. Elkins, M. R. et al "Effect of airway clearance techniques on the efficacy of the sputum induction procedure." European Respiratory Journal 26.5 (2005): 904-908. Web. 18 Jan. 2020.

  5. Atasoy, U.

    1. Fan, J. et al "The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy." European Respiratory Journal 26.5 (2005): 933-947. Web. 18 Jan. 2020.

B

  1. Baraldi, E.

    1. Bonetto, G. et al "A 3-year-old child with abdominal pain and fever." European Respiratory Journal 26.5 (2005): 974-977. Web. 18 Jan. 2020.

  2. Bauer, T. T.

    1. Orth, M. et al "Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy." European Respiratory Journal 26.5 (2005): 898-903. Web. 18 Jan. 2020.

  3. Beaupré, A.

    1. Gadoury, M-A. et al "Self-management reduces both short- and long-term hospitalisation in COPD." European Respiratory Journal 26.5 (2005): 853-857. Web. 18 Jan. 2020.

  4. BĂ©gin, R.

    1. Gadoury, M-A. et al "Self-management reduces both short- and long-term hospitalisation in COPD." European Respiratory Journal 26.5 (2005): 853-857. Web. 18 Jan. 2020.

  5. Bel, E. H.

    1. ten Brinke, A. et al "Risk factors of frequent exacerbations in difficult-to-treat asthma." European Respiratory Journal 26.5 (2005): 812-818. Web. 18 Jan. 2020.

  6. Benden, C.

    1. Benden, C. et al "The Chrispin–Norman score in cystic fibrosis: doing away with the lateral view." European Respiratory Journal 26.5 (2005): 894-897. Web. 18 Jan. 2020.

  7. Bloksma, N.

    1. van Oosterhout, A. J. M., and N. Bloksma. "Regulatory T-lymphocytes in asthma." European Respiratory Journal 26.5 (2005): 918-932. Web. 18 Jan. 2020.

  8. Bonetto, G.

    1. Bonetto, G. et al "A 3-year-old child with abdominal pain and fever." European Respiratory Journal 26.5 (2005): 974-977. Web. 18 Jan. 2020.

  9. Bourbeau, J.

    1. Gadoury, M-A. et al "Self-management reduces both short- and long-term hospitalisation in COPD." European Respiratory Journal 26.5 (2005): 853-857. Web. 18 Jan. 2020.

  10. Boutet, S.

    1. Vogelmeier, C. et al "Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?." European Respiratory Journal 26.5 (2005): 819-828. Web. 18 Jan. 2020.

  11. Brusasco, V.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  12. Buitrago-Tellez, C.

    1. Tueller, C. et al "Value of smear and PCR in bronchoalveolar lavage fluid in culture positive pulmonary tuberculosis." European Respiratory Journal 26.5 (2005): 767-772. Web. 18 Jan. 2020.

  13. Burgos, F.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  14. Bye, P. T. P.

    1. Elkins, M. R. et al "Effect of airway clearance techniques on the efficacy of the sputum induction procedure." European Respiratory Journal 26.5 (2005): 904-908. Web. 18 Jan. 2020.

C

  1. Canioni, D.

    1. Montani, D. et al "Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease." European Respiratory Journal 26.5 (2005): 969-972. Web. 18 Jan. 2020.

  2. Capstick, T.

    1. Capstick, T., and M. T. Henry. "Efficacy of thrombolytic agents in the treatment of pulmonary embolism." European Respiratory Journal 26.5 (2005): 864-874. Web. 18 Jan. 2020.

  3. Carraro, S.

    1. Bonetto, G. et al "A 3-year-old child with abdominal pain and fever." European Respiratory Journal 26.5 (2005): 974-977. Web. 18 Jan. 2020.

  4. Casaburi, R.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  5. Chhajed, P. N.

    1. Tueller, C. et al "Value of smear and PCR in bronchoalveolar lavage fluid in culture positive pulmonary tuberculosis." European Respiratory Journal 26.5 (2005): 767-772. Web. 18 Jan. 2020.

  6. Christiani, D. C.

    1. Wang, X-R. et al "A 20-year follow-up study on chronic respiratory effects of exposure to cotton dust." European Respiratory Journal 26.5 (2005): 881-886. Web. 18 Jan. 2020.

  7. Chung, K. F.

    1. Chung, K. F., and I. M. Adcock. "Signalling and transcriptional regulation in inflammatory and immune cells: importance in lung biology and disease." European Respiratory Journal 26.5 (2005): 762-763. Web. 18 Jan. 2020.

  8. Coates, A.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  9. Crapo, R. O.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

D

  1. D'Urzo, A.

    1. Vogelmeier, C. et al "Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?." European Respiratory Journal 26.5 (2005): 819-828. Web. 18 Jan. 2020.

  2. Dai, H-L.

    1. Wang, X-R. et al "A 20-year follow-up study on chronic respiratory effects of exposure to cotton dust." European Respiratory Journal 26.5 (2005): 881-886. Web. 18 Jan. 2020.

  3. Delaunois, L.

    1. Quaden, C. et al "Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluations." European Respiratory Journal 26.5 (2005): 778-785. Web. 18 Jan. 2020.

  4. Delobbe, A.

    1. Quaden, C. et al "Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluations." European Respiratory Journal 26.5 (2005): 778-785. Web. 18 Jan. 2020.

  5. Demedts, M.

    1. Quaden, C. et al "Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluations." European Respiratory Journal 26.5 (2005): 778-785. Web. 18 Jan. 2020.

  6. de Zeeuw, J.

    1. Orth, M. et al "Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy." European Respiratory Journal 26.5 (2005): 898-903. Web. 18 Jan. 2020.

  7. Dinwiddie, R.

    1. Benden, C. et al "The Chrispin–Norman score in cystic fibrosis: doing away with the lateral view." European Respiratory Journal 26.5 (2005): 894-897. Web. 18 Jan. 2020.

  8. Donaldson, G. C.

    1. Hurst, J. R. et al "Epidemiological relationships between the common cold and exacerbation frequency in COPD." European Respiratory Journal 26.5 (2005): 846-852. Web. 18 Jan. 2020.

  9. Duchna, H-W.

    1. Orth, M. et al "Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy." European Respiratory Journal 26.5 (2005): 898-903. Web. 18 Jan. 2020.

E

  1. Eisen, E. A.

    1. Wang, X-R. et al "A 20-year follow-up study on chronic respiratory effects of exposure to cotton dust." European Respiratory Journal 26.5 (2005): 881-886. Web. 18 Jan. 2020.

  2. Elkins, M. R.

    1. Elkins, M. R. et al "Effect of airway clearance techniques on the efficacy of the sputum induction procedure." European Respiratory Journal 26.5 (2005): 904-908. Web. 18 Jan. 2020.

  3. Erb, T. O.

    1. Trachsel, D. et al "Use of continuous positive airway pressure during flexible bronchoscopy in young children." European Respiratory Journal 26.5 (2005): 773-777. Web. 18 Jan. 2020.

  4. Erginel, S.

    1. Metintas, M. et al "Nonmalignant pleural lesions due to environmental exposure to asbestos: a field-based, cross-sectional study." European Respiratory Journal 26.5 (2005): 875-880. Web. 18 Jan. 2020.

F

  1. Fan, J.

    1. Fan, J. et al "The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy." European Respiratory Journal 26.5 (2005): 933-947. Web. 18 Jan. 2020.

  2. Frei, F. J.

    1. Trachsel, D. et al "Use of continuous positive airway pressure during flexible bronchoscopy in young children." European Respiratory Journal 26.5 (2005): 773-777. Web. 18 Jan. 2020.

  3. Frei, R.

    1. Tueller, C. et al "Value of smear and PCR in bronchoalveolar lavage fluid in culture positive pulmonary tuberculosis." European Respiratory Journal 26.5 (2005): 767-772. Web. 18 Jan. 2020.

  4. Frey, M.

    1. Tueller, C. et al "Value of smear and PCR in bronchoalveolar lavage fluid in culture positive pulmonary tuberculosis." European Respiratory Journal 26.5 (2005): 767-772. Web. 18 Jan. 2020.

G

  1. Gadoury, M-A.

    1. Gadoury, M-A. et al "Self-management reduces both short- and long-term hospitalisation in COPD." European Respiratory Journal 26.5 (2005): 853-857. Web. 18 Jan. 2020.

  2. Garske, L. A.

    1. Elkins, M. R. et al "Effect of airway clearance techniques on the efficacy of the sputum induction procedure." European Respiratory Journal 26.5 (2005): 904-908. Web. 18 Jan. 2020.

  3. Goldberg, H.

    1. Elkins, M. R. et al "Effect of airway clearance techniques on the efficacy of the sputum induction procedure." European Respiratory Journal 26.5 (2005): 904-908. Web. 18 Jan. 2020.

  4. Gorospe, M.

    1. Fan, J. et al "The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy." European Respiratory Journal 26.5 (2005): 933-947. Web. 18 Jan. 2020.

  5. Gustafsson, P.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

H

  1. Hamasaki, Y.

    1. Tsuji, K. et al "dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells." European Respiratory Journal 26.5 (2005): 795-803. Web. 18 Jan. 2020.

  2. Hammer, J.

    1. Trachsel, D. et al "Use of continuous positive airway pressure during flexible bronchoscopy in young children." European Respiratory Journal 26.5 (2005): 773-777. Web. 18 Jan. 2020.

  3. Hang, J-Q.

    1. Wang, X-R. et al "A 20-year follow-up study on chronic respiratory effects of exposure to cotton dust." European Respiratory Journal 26.5 (2005): 881-886. Web. 18 Jan. 2020.

  4. Hankinson, J.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  5. Hector, E.

    1. Elkins, M. R. et al "Effect of airway clearance techniques on the efficacy of the sputum induction procedure." European Respiratory Journal 26.5 (2005): 904-908. Web. 18 Jan. 2020.

  6. Heller, N. M.

    1. Fan, J. et al "The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy." European Respiratory Journal 26.5 (2005): 933-947. Web. 18 Jan. 2020.

  7. Henry, M. T.

    1. Capstick, T., and M. T. Henry. "Efficacy of thrombolytic agents in the treatment of pulmonary embolism." European Respiratory Journal 26.5 (2005): 864-874. Web. 18 Jan. 2020.

  8. Hermine, O.

    1. Montani, D. et al "Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease." European Respiratory Journal 26.5 (2005): 969-972. Web. 18 Jan. 2020.

  9. Hillerdal, G.

    1. Metintas, M. et al "Nonmalignant pleural lesions due to environmental exposure to asbestos: a field-based, cross-sectional study." European Respiratory Journal 26.5 (2005): 875-880. Web. 18 Jan. 2020.

  10. Hirvonen, M-R.

    1. Stark, H. J. et al "The effects of Aspergillus fumigatus challenge on exhaled and nasal NO levels." European Respiratory Journal 26.5 (2005): 887-893. Web. 18 Jan. 2020.

  11. Hoeper, M. M.

    1. Hoeper, M. M. et al "Goal-oriented treatment and combination therapy for pulmonary arterial hypertension." European Respiratory Journal 26.5 (2005): 858-863. Web. 18 Jan. 2020.

  12. Humbert, M.

    1. Montani, D. et al "Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease." European Respiratory Journal 26.5 (2005): 969-972. Web. 18 Jan. 2020.

  13. Hurst, J. R.

    1. Hurst, J. R. et al "Epidemiological relationships between the common cold and exacerbation frequency in COPD." European Respiratory Journal 26.5 (2005): 846-852. Web. 18 Jan. 2020.

I

  1. Ichimaru, T.

    1. Tsuji, K. et al "dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells." European Respiratory Journal 26.5 (2005): 795-803. Web. 18 Jan. 2020.

  2. Imboden, M.

    1. Senn, O. et al "α1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants." European Respiratory Journal 26.5 (2005): 909-917. Web. 18 Jan. 2020.

  3. Ind, P. W.

    1. Ind, P. W.. "COPD disease progression and airway inflammation: uncoupled by smoking cessation." European Respiratory Journal 26.5 (2005): 764-766. Web. 18 Jan. 2020.

J

  1. Jaspal, M.

    1. Vogelmeier, C. et al "Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?." European Respiratory Journal 26.5 (2005): 819-828. Web. 18 Jan. 2020.

  2. Jensen, R.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  3. Jiang, T-X.

    1. Wang, X. et al "Granulocytosis and increased adhesion molecules after resistive loading of the diaphragm." European Respiratory Journal 26.5 (2005): 786-794. Web. 18 Jan. 2020.

  4. Johnson, D. C.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  5. Johnson, W. C.

    1. Johnson, W. C., and G. Raghu. "Clinical trials in idiopathic pulmonary fibrosis: a word of caution concerning choice of outcome measures." European Respiratory Journal 26.5 (2005): 755-758. Web. 18 Jan. 2020.

  6. Julien, M.

    1. Gadoury, M-A. et al "Self-management reduces both short- and long-term hospitalisation in COPD." European Respiratory Journal 26.5 (2005): 853-857. Web. 18 Jan. 2020.

K

  1. Kobayashi, I.

    1. Tsuji, K. et al "dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells." European Respiratory Journal 26.5 (2005): 795-803. Web. 18 Jan. 2020.

  2. Kotterba, S.

    1. Orth, M. et al "Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy." European Respiratory Journal 26.5 (2005): 898-903. Web. 18 Jan. 2020.

L

  1. Lane, T.

    1. Elkins, M. R. et al "Effect of airway clearance techniques on the efficacy of the sputum induction procedure." European Respiratory Journal 26.5 (2005): 904-908. Web. 18 Jan. 2020.

  2. Leidag, M.

    1. Orth, M. et al "Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy." European Respiratory Journal 26.5 (2005): 898-903. Web. 18 Jan. 2020.

  3. Lesman-Leegte, I. G. A. T.

    1. Willemse, B. W. M. et al "Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers." European Respiratory Journal 26.5 (2005): 835-845. Web. 18 Jan. 2020.

M

  1. MacIntyre, N.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  2. Malin, J-P.

    1. Orth, M. et al "Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy." European Respiratory Journal 26.5 (2005): 898-903. Web. 18 Jan. 2020.

  3. Maltais, F.

    1. Gadoury, M-A. et al "Self-management reduces both short- and long-term hospitalisation in COPD." European Respiratory Journal 26.5 (2005): 853-857. Web. 18 Jan. 2020.

  4. Marcelin, A. G.

    1. Montani, D. et al "Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease." European Respiratory Journal 26.5 (2005): 969-972. Web. 18 Jan. 2020.

  5. Marchetto, L.

    1. Elkins, M. R. et al "Effect of airway clearance techniques on the efficacy of the sputum induction procedure." European Respiratory Journal 26.5 (2005): 904-908. Web. 18 Jan. 2020.

  6. Markevych, I.

    1. Hoeper, M. M. et al "Goal-oriented treatment and combination therapy for pulmonary arterial hypertension." European Respiratory Journal 26.5 (2005): 858-863. Web. 18 Jan. 2020.

  7. Masclee, A. A. M.

    1. ten Brinke, A. et al "Risk factors of frequent exacerbations in difficult-to-treat asthma." European Respiratory Journal 26.5 (2005): 812-818. Web. 18 Jan. 2020.

  8. McFawn, P. K.

    1. Noble, P. B. et al "Airway narrowing in porcine bronchi with and without lung parenchyma." European Respiratory Journal 26.5 (2005): 804-811. Web. 18 Jan. 2020.

  9. McKay, R.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  10. Merino, J. M.

    1. Vogelmeier, C. et al "Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?." European Respiratory Journal 26.5 (2005): 819-828. Web. 18 Jan. 2020.

  11. Metintas, M.

    1. Metintas, M. et al "Nonmalignant pleural lesions due to environmental exposure to asbestos: a field-based, cross-sectional study." European Respiratory Journal 26.5 (2005): 875-880. Web. 18 Jan. 2020.

  12. Metintas, S.

    1. Metintas, M. et al "Nonmalignant pleural lesions due to environmental exposure to asbestos: a field-based, cross-sectional study." European Respiratory Journal 26.5 (2005): 875-880. Web. 18 Jan. 2020.

  13. Miller, M. R.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  14. Mitchell, H. W.

    1. Noble, P. B. et al "Airway narrowing in porcine bronchi with and without lung parenchyma." European Respiratory Journal 26.5 (2005): 804-811. Web. 18 Jan. 2020.

  15. Montani, D.

    1. Montani, D. et al "Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease." European Respiratory Journal 26.5 (2005): 969-972. Web. 18 Jan. 2020.

  16. Muro, E.

    1. Tsuji, K. et al "dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells." European Respiratory Journal 26.5 (2005): 795-803. Web. 18 Jan. 2020.

N

  1. Nault, D.

    1. Gadoury, M-A. et al "Self-management reduces both short- and long-term hospitalisation in COPD." European Respiratory Journal 26.5 (2005): 853-857. Web. 18 Jan. 2020.

  2. Navajas, D.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  3. Naya, I.

    1. Vogelmeier, C. et al "Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?." European Respiratory Journal 26.5 (2005): 819-828. Web. 18 Jan. 2020.

  4. Niedermeyer, J.

    1. Hoeper, M. M. et al "Goal-oriented treatment and combination therapy for pulmonary arterial hypertension." European Respiratory Journal 26.5 (2005): 858-863. Web. 18 Jan. 2020.

  5. Nishi, N.

    1. Tsuji, K. et al "dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells." European Respiratory Journal 26.5 (2005): 795-803. Web. 18 Jan. 2020.

  6. Noble, P. B.

    1. Noble, P. B. et al "Airway narrowing in porcine bronchi with and without lung parenchyma." European Respiratory Journal 26.5 (2005): 804-811. Web. 18 Jan. 2020.

O

  1. Olenchock, S. A.

    1. Wang, X-R. et al "A 20-year follow-up study on chronic respiratory effects of exposure to cotton dust." European Respiratory Journal 26.5 (2005): 881-886. Web. 18 Jan. 2020.

  2. Orth, M.

    1. Orth, M. et al "Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy." European Respiratory Journal 26.5 (2005): 898-903. Web. 18 Jan. 2020.

  3. Ou, W.

    1. Tsuji, K. et al "dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells." European Respiratory Journal 26.5 (2005): 795-803. Web. 18 Jan. 2020.

  4. Owens, C. M.

    1. Benden, C. et al "The Chrispin–Norman score in cystic fibrosis: doing away with the lateral view." European Respiratory Journal 26.5 (2005): 894-897. Web. 18 Jan. 2020.

P

  1. Pagliuso, J.

    1. Elkins, M. R. et al "Effect of airway clearance techniques on the efficacy of the sputum induction procedure." European Respiratory Journal 26.5 (2005): 904-908. Web. 18 Jan. 2020.

  2. Pauwels†, R.

    1. Vogelmeier, C. et al "Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?." European Respiratory Journal 26.5 (2005): 819-828. Web. 18 Jan. 2020.

  3. Pedersen, O. F.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  4. Pellegrino, R.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  5. Perera, W. R.

    1. Hurst, J. R. et al "Epidemiological relationships between the common cold and exacerbation frequency in COPD." European Respiratory Journal 26.5 (2005): 846-852. Web. 18 Jan. 2020.

  6. Postma, D. S.

    1. Willemse, B. W. M. et al "Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers." European Respiratory Journal 26.5 (2005): 835-845. Web. 18 Jan. 2020.

  7. Price, D.

    1. Vogelmeier, C. et al "Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?." European Respiratory Journal 26.5 (2005): 819-828. Web. 18 Jan. 2020.

  8. Probst-Hensch, N. M.

    1. Senn, O. et al "α1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants." European Respiratory Journal 26.5 (2005): 909-917. Web. 18 Jan. 2020.

  9. Purokivi, M. K.

    1. Stark, H. J. et al "The effects of Aspergillus fumigatus challenge on exhaled and nasal NO levels." European Respiratory Journal 26.5 (2005): 887-893. Web. 18 Jan. 2020.

Q

  1. Quaden, C.

    1. Quaden, C. et al "Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluations." European Respiratory Journal 26.5 (2005): 778-785. Web. 18 Jan. 2020.

R

  1. Rabe, K. F.

    1. ten Brinke, A. et al "Risk factors of frequent exacerbations in difficult-to-treat asthma." European Respiratory Journal 26.5 (2005): 812-818. Web. 18 Jan. 2020.

  2. Raghu, G.

    1. Johnson, W. C., and G. Raghu. "Clinical trials in idiopathic pulmonary fibrosis: a word of caution concerning choice of outcome measures." European Respiratory Journal 26.5 (2005): 755-758. Web. 18 Jan. 2020.

  3. Randell, J. T.

    1. Stark, H. J. et al "The effects of Aspergillus fumigatus challenge on exhaled and nasal NO levels." European Respiratory Journal 26.5 (2005): 887-893. Web. 18 Jan. 2020.

  4. Rasche, K.

    1. Orth, M. et al "Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy." European Respiratory Journal 26.5 (2005): 898-903. Web. 18 Jan. 2020.

  5. Redenbach, D. M.

    1. Wang, X. et al "Granulocytosis and increased adhesion molecules after resistive loading of the diaphragm." European Respiratory Journal 26.5 (2005): 786-794. Web. 18 Jan. 2020.

  6. Reid, W. D.

    1. Wang, X. et al "Granulocytosis and increased adhesion molecules after resistive loading of the diaphragm." European Respiratory Journal 26.5 (2005): 786-794. Web. 18 Jan. 2020.

  7. Renzi, P.

    1. Gadoury, M-A. et al "Self-management reduces both short- and long-term hospitalisation in COPD." European Respiratory Journal 26.5 (2005): 853-857. Web. 18 Jan. 2020.

  8. Ridout, D. A.

    1. Benden, C. et al "The Chrispin–Norman score in cystic fibrosis: doing away with the lateral view." European Respiratory Journal 26.5 (2005): 894-897. Web. 18 Jan. 2020.

  9. Road, J. D.

    1. Wang, X. et al "Granulocytosis and increased adhesion molecules after resistive loading of the diaphragm." European Respiratory Journal 26.5 (2005): 786-794. Web. 18 Jan. 2020.

  10. Roponen, M. H.

    1. Stark, H. J. et al "The effects of Aspergillus fumigatus challenge on exhaled and nasal NO levels." European Respiratory Journal 26.5 (2005): 887-893. Web. 18 Jan. 2020.

  11. Rouleau, M.

    1. Gadoury, M-A. et al "Self-management reduces both short- and long-term hospitalisation in COPD." European Respiratory Journal 26.5 (2005): 853-857. Web. 18 Jan. 2020.

  12. Russi, E. W.

    1. Senn, O. et al "α1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants." European Respiratory Journal 26.5 (2005): 909-917. Web. 18 Jan. 2020.

  13. Rutgers, B.

    1. Willemse, B. W. M. et al "Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers." European Respiratory Journal 26.5 (2005): 835-845. Web. 18 Jan. 2020.

S

  1. Sadakane, Y.

    1. Tsuji, K. et al "dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells." European Respiratory Journal 26.5 (2005): 795-803. Web. 18 Jan. 2020.

  2. Scarpa, M.

    1. Bonetto, G. et al "A 3-year-old child with abdominal pain and fever." European Respiratory Journal 26.5 (2005): 974-977. Web. 18 Jan. 2020.

  3. Schmidt, J. T.

    1. ten Brinke, A. et al "Risk factors of frequent exacerbations in difficult-to-treat asthma." European Respiratory Journal 26.5 (2005): 812-818. Web. 18 Jan. 2020.

  4. Schultze-Werninghaus, G.

    1. Orth, M. et al "Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy." European Respiratory Journal 26.5 (2005): 898-903. Web. 18 Jan. 2020.

  5. Schwartzman, K.

    1. Gadoury, M-A. et al "Self-management reduces both short- and long-term hospitalisation in COPD." European Respiratory Journal 26.5 (2005): 853-857. Web. 18 Jan. 2020.

  6. Senn, O.

    1. Senn, O. et al "α1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants." European Respiratory Journal 26.5 (2005): 909-917. Web. 18 Jan. 2020.

  7. Seow, C. Y.

    1. Seow, C. Y.. "Are you pulling my airway?." European Respiratory Journal 26.5 (2005): 759-761. Web. 18 Jan. 2020.

  8. Sharma, A.

    1. Noble, P. B. et al "Airway narrowing in porcine bronchi with and without lung parenchyma." European Respiratory Journal 26.5 (2005): 804-811. Web. 18 Jan. 2020.

  9. Simonneau, G.

    1. Montani, D. et al "Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease." European Respiratory Journal 26.5 (2005): 969-972. Web. 18 Jan. 2020.

  10. Sitbon, O.

    1. Montani, D. et al "Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease." European Respiratory Journal 26.5 (2005): 969-972. Web. 18 Jan. 2020.

  11. Spiekerkoetter, E.

    1. Hoeper, M. M. et al "Goal-oriented treatment and combination therapy for pulmonary arterial hypertension." European Respiratory Journal 26.5 (2005): 858-863. Web. 18 Jan. 2020.

  12. Spinhoven, P.

    1. ten Brinke, A. et al "Risk factors of frequent exacerbations in difficult-to-treat asthma." European Respiratory Journal 26.5 (2005): 812-818. Web. 18 Jan. 2020.

  13. Stark, H. J.

    1. Stark, H. J. et al "The effects of Aspergillus fumigatus challenge on exhaled and nasal NO levels." European Respiratory Journal 26.5 (2005): 887-893. Web. 18 Jan. 2020.

  14. Stellato, C.

    1. Fan, J. et al "The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy." European Respiratory Journal 26.5 (2005): 933-947. Web. 18 Jan. 2020.

  15. Sterk, P. J.

    1. ten Brinke, A. et al "Risk factors of frequent exacerbations in difficult-to-treat asthma." European Respiratory Journal 26.5 (2005): 812-818. Web. 18 Jan. 2020.

  16. Sun, B-X.

    1. Wang, X-R. et al "A 20-year follow-up study on chronic respiratory effects of exposure to cotton dust." European Respiratory Journal 26.5 (2005): 881-886. Web. 18 Jan. 2020.

T

  1. Tamm, M.

    1. Tueller, C. et al "Value of smear and PCR in bronchoalveolar lavage fluid in culture positive pulmonary tuberculosis." European Respiratory Journal 26.5 (2005): 767-772. Web. 18 Jan. 2020.

  2. ten Brinke, A.

    1. ten Brinke, A. et al "Risk factors of frequent exacerbations in difficult-to-treat asthma." European Respiratory Journal 26.5 (2005): 812-818. Web. 18 Jan. 2020.

  3. ten Hacken, N. H. T.

    1. Willemse, B. W. M. et al "Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers." European Respiratory Journal 26.5 (2005): 835-845. Web. 18 Jan. 2020.

  4. Tillie-Leblond, I.

    1. Quaden, C. et al "Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluations." European Respiratory Journal 26.5 (2005): 778-785. Web. 18 Jan. 2020.

  5. Timens, W.

    1. Willemse, B. W. M. et al "Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers." European Respiratory Journal 26.5 (2005): 835-845. Web. 18 Jan. 2020.

  6. Trachsel, D.

    1. Trachsel, D. et al "Use of continuous positive airway pressure during flexible bronchoscopy in young children." European Respiratory Journal 26.5 (2005): 773-777. Web. 18 Jan. 2020.

  7. Tsuji, K.

    1. Tsuji, K. et al "dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells." European Respiratory Journal 26.5 (2005): 795-803. Web. 18 Jan. 2020.

  8. Tueller, C.

    1. Tueller, C. et al "Value of smear and PCR in bronchoalveolar lavage fluid in culture positive pulmonary tuberculosis." European Respiratory Journal 26.5 (2005): 767-772. Web. 18 Jan. 2020.

  9. Tukiainen, H. O.

    1. Stark, H. J. et al "The effects of Aspergillus fumigatus challenge on exhaled and nasal NO levels." European Respiratory Journal 26.5 (2005): 887-893. Web. 18 Jan. 2020.

U

  1. Ucgun, I.

    1. Metintas, M. et al "Nonmalignant pleural lesions due to environmental exposure to asbestos: a field-based, cross-sectional study." European Respiratory Journal 26.5 (2005): 875-880. Web. 18 Jan. 2020.

V

  1. van der Grinten, C. P. M.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  2. van Oosterhout, A. J. M.

    1. van Oosterhout, A. J. M., and N. Bloksma. "Regulatory T-lymphocytes in asthma." European Respiratory Journal 26.5 (2005): 918-932. Web. 18 Jan. 2020.

  3. Van Sickle, D.

    1. Van Sickle, D.. "Perceptions of asthma among physicians: an exploratory study with the ISAAC video." European Respiratory Journal 26.5 (2005): 829-834. Web. 18 Jan. 2020.

  4. Verstraeten, A.

    1. Quaden, C. et al "Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluations." European Respiratory Journal 26.5 (2005): 778-785. Web. 18 Jan. 2020.

  5. Viard, J-P.

    1. Montani, D. et al "Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease." European Respiratory Journal 26.5 (2005): 969-972. Web. 18 Jan. 2020.

  6. Viegi, G.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  7. Vogelmeier, C.

    1. Vogelmeier, C. et al "Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?." European Respiratory Journal 26.5 (2005): 819-828. Web. 18 Jan. 2020.

W

  1. Wallaert, B.

    1. Quaden, C. et al "Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluations." European Respiratory Journal 26.5 (2005): 778-785. Web. 18 Jan. 2020.

  2. Wallis, C.

    1. Benden, C. et al "The Chrispin–Norman score in cystic fibrosis: doing away with the lateral view." European Respiratory Journal 26.5 (2005): 894-897. Web. 18 Jan. 2020.

  3. Walther, J. W.

    1. Orth, M. et al "Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy." European Respiratory Journal 26.5 (2005): 898-903. Web. 18 Jan. 2020.

  4. Wang, X-R.

    1. Wang, X-R. et al "A 20-year follow-up study on chronic respiratory effects of exposure to cotton dust." European Respiratory Journal 26.5 (2005): 881-886. Web. 18 Jan. 2020.

  5. Wang, X.

    1. Wang, X. et al "Granulocytosis and increased adhesion molecules after resistive loading of the diaphragm." European Respiratory Journal 26.5 (2005): 786-794. Web. 18 Jan. 2020.

  6. Wanger, J.

    1. Pellegrino, R. et al "Interpretative strategies for lung function tests." European Respiratory Journal 26.5 (2005): 948-968. Web. 18 Jan. 2020.

  7. Wedzicha, J. A.

    1. Hurst, J. R. et al "Epidemiological relationships between the common cold and exacerbation frequency in COPD." European Respiratory Journal 26.5 (2005): 846-852. Web. 18 Jan. 2020.

  8. Wegman, D. H.

    1. Wang, X-R. et al "A 20-year follow-up study on chronic respiratory effects of exposure to cotton dust." European Respiratory Journal 26.5 (2005): 881-886. Web. 18 Jan. 2020.

  9. Welte, T.

    1. Hoeper, M. M. et al "Goal-oriented treatment and combination therapy for pulmonary arterial hypertension." European Respiratory Journal 26.5 (2005): 858-863. Web. 18 Jan. 2020.

  10. Widdig, W.

    1. Orth, M. et al "Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy." European Respiratory Journal 26.5 (2005): 898-903. Web. 18 Jan. 2020.

  11. Wilkinson, T. M. A.

    1. Hurst, J. R. et al "Epidemiological relationships between the common cold and exacerbation frequency in COPD." European Respiratory Journal 26.5 (2005): 846-852. Web. 18 Jan. 2020.

  12. Willemse, B. W. M.

    1. Willemse, B. W. M. et al "Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers." European Respiratory Journal 26.5 (2005): 835-845. Web. 18 Jan. 2020.

Y

  1. Yamamoto, S.

    1. Tsuji, K. et al "dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells." European Respiratory Journal 26.5 (2005): 795-803. Web. 18 Jan. 2020.

  2. Yildirim, H.

    1. Metintas, M. et al "Nonmalignant pleural lesions due to environmental exposure to asbestos: a field-based, cross-sectional study." European Respiratory Journal 26.5 (2005): 875-880. Web. 18 Jan. 2020.

Z

  1. Zaitsu, M.

    1. Tsuji, K. et al "dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells." European Respiratory Journal 26.5 (2005): 795-803. Web. 18 Jan. 2020.

  2. Zhang, H-X.

    1. Wang, X-R. et al "A 20-year follow-up study on chronic respiratory effects of exposure to cotton dust." European Respiratory Journal 26.5 (2005): 881-886. Web. 18 Jan. 2020.

  3. Zwinderman, A. H.

    1. ten Brinke, A. et al "Risk factors of frequent exacerbations in difficult-to-treat asthma." European Respiratory Journal 26.5 (2005): 812-818. Web. 18 Jan. 2020.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts